Literature DB >> 29157829

Sulfated galactans from the red seaweed Gracilaria fisheri exerts anti-migration effect on cholangiocarcinoma cells.

Thannicha Sae-Lao1, Natthanej Luplertlop2, Tavan Janvilisri3, Rutaiwan Tohtong3, David O Bates4, Kanokpan Wongprasert5.   

Abstract

BACKGROUND: Seaweeds have a long history of use in Asian countries as functional foods, medicinal herbs, and the treatment of cancer. Polysaccharides from various seaweeds have shown anti-tumor activity. Cholangiocarcinoma (CCA), often with metastatic disease, is highly prevalent in Thailand as a consequence of liver fluke infection. Recently, we extracted sulfated galactans (SG) from Gracilaria fisheri (G. fisheri), a south east Asian seaweed, and found it exhibited anti-proliferation effect on CCA cells.
PURPOSE: In the present study, we evaluated the anti-migration activity of SG on CCA cells and its underlined mechanism.
METHODS: CCA cells were treated with SG alone or drugs targeting to epidermal growth factor (EGF) receptor (EGFR) or pretreated with SG prior to incubation with EGF. Anti-migration activity was determined using a scratch wound-healing assay and zymography. Immunofluorescence staining and western blotting were used to investigate EGFR signaling mediators.
RESULTS: Under basal condition, SG reduced the migration rate of CCA, which was correlated with a decrease in the active-form of matrix metalloproteinases-9. SG decreased expression of phosphorylated focal adhesion kinase (FAK), but increased expression of E-cadherin to promote cells stasis. Moreover, phosphorylation of EGFR and extracellular signal-regulated kinases (ERK), known to stimulate growth of cancer cells, was blocked in a comparable way to EGFR inhibitors Cetuximab and Erlotinib. Pretreatment cells with SG attenuated EGF induced phosphorylation of EGFR, ERK and FAK.
CONCLUSION: This study reveals that SG from G. fisheri retards migration of CCA cells, and its mechanism of inhibition is mediated, to some extent, by inhibitory effects on MAPK/ERK signal transduction pathway. Our findings suggest that there may be a therapeutic potential of SG in CCA treatment.
Copyright © 2017 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Anti-migration; Cholangiocarcinoma; Epidermal growth factor receptor; Gracilaria fisheri; Mitogen-activated kinases/extracellular signal-regulated kinases; Sulfated galactans

Mesh:

Substances:

Year:  2017        PMID: 29157829     DOI: 10.1016/j.phymed.2017.09.014

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  4 in total

1.  Probing the Anti-Cancer Potency of Sulfated Galactans on Cholangiocarcinoma Cells Using Synchrotron FTIR Microspectroscopy, Molecular Docking, and In Vitro Studies.

Authors:  Boonyakorn Boonsri; Kiattawee Choowongkomon; Buabarn Kuaprasert; Thanvarin Thitiphatphuvanon; Kittiya Supradit; Apinya Sayinta; Jinchutha Duangdara; Tawut Rudtanatip; Kanokpan Wongprasert
Journal:  Mar Drugs       Date:  2021-04-30       Impact factor: 5.118

2.  Study on Absorption Mechanism and Tissue Distribution of Fucoidan.

Authors:  Xu Bai; E Zhang; Bo Hu; Hao Liang; Shuliang Song; Aiguo Ji
Journal:  Molecules       Date:  2020-02-28       Impact factor: 4.411

3.  Upregulation of miR‑132‑3p in cholangiocarcinoma tissues: A study based on RT‑qPCR, The Cancer Genome Atlas miRNA sequencing, Gene Expression Omnibus microarray data and bioinformatics analyses.

Authors:  Hua-Yu Wu; Shuang Xia; An-Gui Liu; Min-Da Wei; Zhong-Biao Chen; Yu-Xin Li; Yu He; Min-Jun Liao; Qi-Ping Hu; Shang-Ling Pan
Journal:  Mol Med Rep       Date:  2019-10-07       Impact factor: 2.952

4.  A Sulfated Polysaccharide from Red Algae (Gelidium crinale) to Suppress Cells Metastasis and MMP-9 Expression of HT1080 Cells.

Authors:  Haiyan Zheng; Yu Pei; Yuan-Lin He; Yi Liu; Minqi Chen; Pengzhi Hong; Chunxia Zhou; Zhong-Ji Qian
Journal:  Foods       Date:  2022-08-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.